孙冰,郭蕊,陈蕊蕊,薛凯

• 1:中国人民解放军空军军医大学第二附属医院心内科

摘要(Abstract)：

肺栓塞是一种死亡率高且会引起远期不良预后的心血管疾病。长期以来，抗凝和全身溶栓是治疗肺栓塞的主要手段。近年来，导管溶栓被越来越多地应用到了肺栓塞的治疗当中。与单独抗凝相比，导管溶栓可以更快、更有效地降低肺动脉压力、改善右心室功能；与全身溶栓相比，导管溶栓可以减少出血发生率，应用更安全，使用范围更广。然而由于相关临床试验数据的缺乏，相关指南对导管溶栓都只是Ⅱ类推荐。本文将对导管溶栓治疗肺栓塞的最新研究进行回顾，以期找出最合理的治疗使用方案。

关键词(KeyWords)： 肺栓塞;导管溶栓;抗凝

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 孙冰,郭蕊,陈蕊蕊,薛凯

参考文献(References)：

• [1] Konstantinides SV,Meyer G,Becattini C,et al.2019E S C guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society(ERS):the task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology(ESC)[J]. Eur Respir J,2019,54(3):1901647.
• [2] Wendelboe AM,Raskob GE. Global burden of thrombosis:epidemiologic aspects[J]. Circ Res,2016,118(9):1340-1347.
• [3] Keller K,Hobohm L,Ebner M,et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany[J]. Eur Heart J,2020,41(4):522-529.
• [4] Lehnert P,Lange T,M?ller CH,et al. Acute pulmonary embolism in a national danish cohort:increasing incidence and decreasing mortality[J]. Thromb Haemost,2018,118(3):539-546.
• [5] Marti C,John G,Konstantinides S,et al. Systemic thrombolytic therapy for acute pulmonary embolism:a systematic review and meta-analysis[J]. Eur Heart J,2015,36(10):605-614.
• [6] Giri J,Sista AK,Weinberg I,et al. Interventional therapies for acute pulmonary embolism:current status and principles for the development of novel evidence:a scientific statement from the American Heart Association[J]. Circulation,2019,140(20):e774-e801.
• [7] Gayou EL,Makary MS,Hughes DR,et al. Nationwide trends in use of catheter-directed therapy for treatment of pulmonary embolism in medicare benefi ciaries from 2004 to 2016[J]. J Vasc Interv Radiol, 2019,30(6):801-806.
• [8] Stein PD,Matta F,Hughes MJ. Catheter-directed thrombolysis in submassive pulmonary embolism and acute cor pulmonale[J].Am J Cardiol,2020,131:109-114.
• [9] Kabrhel C,Ali A,Choi JG,et al. Systemic thrombolysis,catheter-directed thrombolysis,and anticoagulation for intermediate-risk pulmonary embolism:a simulation modeling analysis[J]. Acad Emerg Med,2017,24(10):1235-1243.
• [10] Siddiqi F,Odrljin TM,Fay PJ,et al. Binding of tissueplasminogen activator to fibrin:effect of ultrasound[J].Blood,1998,91(6):2019-2025.
• [11] St?pniewski J,Kope?G,Musia?ek P,et al. Hemodynamic ef fects of ultrasound-assisted,catheter-directed,very low-dose,short-time duration thrombolysis in acute intermediate-high risk pulmonary embolism(from the EKOS-PL study)[J]. Am J Cardiol,2021,141:133-139.
• [12] Haywood HB,Pauley E,Orgel R,et al. Fibrinogen levels and bleeding risk in patients undergoing ultrasound-assisted catheterdirected thrombolysis for submassive pulmonary embolism[J]. J Invasive Cardiol,2021,33(9):E702-E708.
• [13] Avgerinos ED,Saadeddin Z,Abou Ali AN,et al. A metaanalysis of outcomes of catheter-directed thrombolysis for high-and intermediate-risk pulmonary embolism[J]. J Vasc Surg Venous Lymphat Disord,2018,6(4):530-540.
• [14] Pei DT,Liu J,Yaqoob M,et al. Meta-analysis of catheter directed ultrasound-assisted thrombolysis in pulmonary embolism[J]. Am J Cardiol,2019,12 4(9):1470-1477.
• [15] Wu J,Chen H,Yu Y,et al.Feasibility of ultrasound-assisted catheter-directed thrombolysis for submassive pulmonary embolism:a meta-analysis of case series[J]. Clin Respir J,2020,14(5):430-439.
• [16] Knox MF,Langholz DE,Berjaoui WK,et al. Preservation of cardiopulmonary function in patients treated with ultrasoundaccelerated thrombolysis in the setting of submassive pulmonary embolism[J]. J Vasc Interv Radiol,2019,30(5):734-741.
• [17] Makary MS,Fogler BD,Dube PP,et al. Ultrasoundaccelerated,catheter-directed thrombolysis for submassive pulmonary embolism:single-center retrospective review with intermediate-term outcomes[J]. J Vasc Interv Radiol,2020,31(3):438-443.
• [18] Seropian IM,Rojas Matas CA,Damonte JI,et al. Estudio unicéntrico del tratamiento con trombolíticos dirigidos por catéter en el tromboembolismo pulmonar agudo[single center retrospective study of catheter directed thrombolysis in patients with acute pulmonary embolism][J]. Medicina(B Aires),2021,81(3):382-388.
• [19] Herzig M,Khandhar S,Palevsky H,et al. Intermediate-term outcomes for patients with submassive pulmonary embolism treated with catheter-directed thrombolysis[J]. J Invasive Cardiol,2021,33(12):E949-E953.
• [20] Tapson VF,Sterling K,Jones N,et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism:the OPTALYSE PE trial[J]. JACC Cardiovasc Interv,2018,11(14):1401-1410.
• [21] Tran D,Hays N,Shah A,et al. Ultrasound-assisted catheter directed thrombolysis for pulmonary embolus during extracorporeal membrane oxygenation[J]. J Card Surg,2021,36(8):2685-2691.
• [22] Harrison E,Kim JS,Lakhter V,et al. Safety and e ffi cacy of catheter directed thrombolysis(CDT)in elderly with pulmonary embolism(PE)[J]. BMJ Open Respir Res, 2021,8(1):e000894.
• [23] Schmitz A,Schacht M,Butty S. Repeat angiography in patients undergoing conventional catheter-directed thrombolysis for submassive pulmonary embolism:a large single-center experience[J]. Diagn Interv Radiol,2021,27(5):664-670.
• [24] Graif A,Patel KD,Wimmer NJ,et al. Evaluation of the benefi t of extended catheter-directed thrombolysis with serial angiography for acute pulmonary embolism[J]. J Vasc Interv Radiol,2021,32(1):70-79.
• [25] C h e r f a n P, A b o u A l i A N, Z a g h l o u l M S, e t a l.P r o p o f o l administration during catheter-directed interventions for intermediate-risk pulmonary embolism is associated with major adverse events[J]. J Vasc Surg Venous Lymphat Disord,2021,9(3):621-626.
• [26] Kucher N,Boekstegers P,Müller OJ,et al. Randomized,controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism[J].Circulation,2014,129(4):479-486.
• [27] Derya Omaygenc DO,Omaygenc MO. Comparison of catheter-directed thrombolysis and anticoagulation in intermediaterisk pulmonary embolism:a retrospective analysis[J]. Eurasian J Pulmonol,2021,23:50-58.
• [28] Schissler AJ,Gylnn RJ,Sobieszczyk PS,et al. Ultrasoundassisted catheter-directed thrombolysis compared with anticoagulation alone for treatment of intermediate-risk pulmonary embolism[J].Pulm Circ,2018,8(4):1-7.
• [29] Sekulic I,Dzudovic B,Matijasevic J,et al. Ultrasound assisted thrombolysis in intermediate-risk patients with pulmonary thromboembolism[J]. Acta Cardiol,2019,1:1-8.
• [30] D’Auria S,Sezer A,Thoma F,et al. Outcomes of catheterdirected thrombolysis vs. standard medical therapy in patients with acute submassive pulmonary embolism[J]. Pulm Circ,2020,10(1):1-8.
• [31] Kline TM,Rodino AM,Dorszynski A,et al. Ultrasound-assisted catheter-directed thrombolysis versus systemic anticoagulation alone for submassive pulmonary embolism[J]. J Thromb Thrombolysis,2021,52(1):130-137.
• [32] Johnson K,VandenHull A,Remund T,et al. Short-term cost comparison of systemic heparin therapy vs. catheter directed thrombolysis for the treatment of massive and submassive pulmonary embolism with long-term chronic pulmonary hypertension cost model[J]. S D Med,2021,74(2):70-74.
• [33] Beyer SE,Shanafelt C,Pinto DS,et al. Utilization and outcomes of thrombolytic therapy for acute pulmonary embolism:a nationwide cohort study[J]. Chest,2020,157(3):645-653.
• [34] Geller BJ,Adusumalli S,Pugliese SC,et al. Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism:a real-world analysis of national administrative claims[J]. Vasc Med,2020,25(4):334-340.
• [35] Lin DS,Lin YS,Wu CK,et al. Midterm prognosis o f patients with pulmonary embolism receiving catheterdirected thrombolysis or systemic thrombolysis:a nationwide population-based study[J]. J Am Heart Assoc,2021,10(7):e019296.
• [36] Sharifi M,Awdisho A,Schroeder B,et al. Retrospective comparison of ultrasound facilitated catheter-directed thrombolysis and systemically administered half-dose thrombolysis in treatment of pulmonary embolism[J]. Vasc Med,2019,24(2):103-109.
• [37] Lin PH,Annambhotla S,Bechara CF,et al. Comparison of percutaneous ultrasound-accelerated thrombolysis versus catheterdirected thrombolysis in patients with acute massive pulmonary embolism[J]. Vascular,2009,17 Suppl 3:S137-S147.
• [38] Liang NL,Avgerinos ED,Marone LK,et al. Comparative outcomes of ultrasound-assisted thrombolysis and standard catheterdirected thrombolysis in the treatment of acute pulmonary embolism[J]. Vasc Endovascular Surg,2016,50(6):405-410.
• [39] Graif A,Grilli CJ,Kimbiris G,et al. Comparison of ultrasoundaccelerated versus pigtail catheter-directed thrombolysis for the treatment of acute massive and submassive pulmonary embolism[J]. J Vasc Interv Radiol,2017,28(10):1339-1347.
• [40] Rao G,Xu H,Wang JJ,et al. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute pulmonary embolism:a multicenter comparison of patient-centered outcomes[J]. Vasc Med,2019,24(3):241-247.
• [41] Rothschild DP,Goldstein JA,Ciacci J,et al. Ultrasoundaccelerated thrombolysis(USAT)versus standard catheterdirected thrombolysis(CDT)for treatment of pulmonary embolism:a retrospective analysis[J]. Vasc Med,2019,24(3):234-240.
• [42] Allen S,Chan L,Masic D,et al. Comparison of outcomes in catheter-directed versus ultrasound-assisted thrombolysis for management of submassive pulmonary embolism[J]. Thromb Res,2021,202:96-99.
• [43] Avgerinos ED,Jaber W,Lacomis J,et al. Randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism:the SUNSET sPE trial[J].JACC Cardiovasc Interv,2021,14(12):1364-1373.
• [44]中华医学会呼吸病学分会肺栓塞与肺血管病学组，中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会，全国肺栓塞与肺血管病防治协作组.《肺血栓栓塞症诊治与预防指南》[J].中华医学杂志，2018,98(14):1060-1087.
• [45] Kabrhel C,Rosovsky R,Channick R,et al. A multidisciplinary pulmonary embolism response team:initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism[J]. Chest,2016,150(2):384-393.